1-6 of 6
Jennifer Paleveda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

Clinical Trials & Observations
Mikkael A. Sekeres, Ramon V. Tiu, Rami Komrokji, Jeffrey Lancet, Anjali S. Advani, Manuel Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, Jennifer Paleveda, Ali Tabarroki, Valeria Visconte, Hideki Makishima, Andres Jerez, Ronald Paquette, Alan F. List, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2012) 120 (25): 4945–4951.
https://doi.org/10.1182/blood-2012-06-434639
Published: 2012
Includes: Supplemental data
Journal Articles

Response Adapted Therapy Using Single Agent Lenalidomide in Older Adults with Newly Diagnosed Standard Risk Multiple Myeloma

Rachid Baz, MD, Melissa Alsina, MD, Kenneth H. Shain, MD, PhD, Jennifer Paleveda, Nancy Hillgruber, RN, Elizabeth Finley-Oliver, RN, Leonel Ochoa, MD, Taiga Nishihori, MD, William Dalton, PhD, MD, Daniel Sullivan, MD
Journal: Blood
Blood (2012) 120 (21): 4060.
https://doi.org/10.1182/blood.V120.21.4060.4060
Published: 2012
Journal Articles

Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome

Clinical Trials & Observations
Rami S. Komrokji, Jeffrey E. Lancet, Arlene S. Swern, Nianhang Chen, Jennifer Paleveda, Richard Lush, Hussain I. Saba, Alan F. List
Journal: Blood
Blood (2012) 120 (17): 3419–3424.
https://doi.org/10.1182/blood-2012-03-415661
Published: 2012
Journal Articles

Final Results From the Phase 2 Continuation Study of the Lenalidomide and Azacitidine Combination in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Mikkael A. Sekeres, MD, MS, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Ramon V. Tiu, MD, Anjali S. Advani, MD, Manual Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, M.S., Jennifer Paleveda, Ronald Paquette, MD, PhD, April Smith, Lori Strozniak, Alan F. List, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 607.
https://doi.org/10.1182/blood.V118.21.607.607
Published: 2011
Journal Articles

Updated Results of the Phase II Study of Pegylated Liposomal Doxorubicin (PLD), Low Dose Dexamethasone (DEX) and Lenalidomide (LEN) In Patients with Newly Diagnosed (ND) Multiple Myeloma (MM)

Rachid Baz, MD, Mohamad A Hussein, MD, Daniel Sullivan, MD, Jose-Leonel Ochoa-Bayona, M.D., Monique A Hartley, MD, Kenneth Shain, MD, PhD, Taiga Nishihori, MD, Jennifer Paleveda, Kara Kosakowski, William S. Dalton, PhD, MD, Melissa Alsina, MD
Journal: Blood
Blood (2010) 116 (21): 3054.
https://doi.org/10.1182/blood.V116.21.3054.3054
Published: 2010
Journal Articles

Phase 2 Multicenter Trial of Rabbit Anti-Thymocyte Serotherapy In Myelodysplastic Syndrome: Rate of Hematological Improvement Associated with Pre-Treatment Disease Duration

P.K. Epling-Burnette, PharmD, PhD, Rami S. Komrokji, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS, Ronald Paquette, MD, Sheng Wei, MD, Jeffrey S Painter, BS, Fanqi Bai, MD, William J Fulp, Jennifer Paleveda-Pena, Dung-Tsa Chen, PhD, Alan F. List, MD
Journal: Blood
Blood (2010) 116 (21): 602.
https://doi.org/10.1182/blood.V116.21.602.602
Published: 2010